Literature DB >> 1332032

O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA.

S J Chanock1, L R Faust, D Barrett, C Bizal, F E Maly, P E Newburger, J M Ruedi, R M Smith, B M Babior.   

Abstract

The respiratory burst oxidase of phagocytes and B lymphocytes is a complicated enzyme that catalyzes the one-electron reduction of oxygen by NADPH. It is responsible for the O2- production that occurs when these cells are exposed to phorbol 12-myristate 13-acetate or other appropriate stimuli. The activity of this enzyme is greatly decreased or absent in patients with chronic granulomatous disease, an inherited disorder characterized by a severe defect in host defense against bacteria and fungi. In every chronic granulomatous disease patient studied to date, an abnormality has been found in a gene encoding one of four components of the respiratory burst oxidase: the membrane protein p22phox or gp91phox, or the cytosolic protein p47phox or p67phox. We report here that O2- production was partly restored to phorbol 12-myristate 13-acetate-stimulated Epstein-Barr virus-transformed B lymphocytes from a patient with p47phox-deficient chronic granulomatous disease by transfection with an expression plasmid containing a p47phox cDNA inserted in the sense direction. No detectable O2- was produced by untransfected p47phox-deficient lymphocytes or by p47phox-deficient lymphocytes transfected with an antisense plasmid. The finding that O2- can be produced by p47phox-deficient B lymphocytes after the transfer of a p47phox cDNA into the deficient cells suggests that this system could be useful for studying the function of mutant p47phox proteins in whole cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332032      PMCID: PMC50300          DOI: 10.1073/pnas.89.21.10174

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1.

Authors:  A Abo; E Pick; A Hall; N Totty; C G Teahan; A W Segal
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

Review 2.  Molecular basis of chronic granulomatous disease.

Authors:  R M Smith; J T Curnutte
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

3.  Ouabain-resistant mutants of the rat Na,K-ATPase alpha 2 isoform identified by using an episomal expression vector.

Authors:  V Canfield; J R Emanuel; N Spickofsky; R Levenson; R F Margolskee
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor.

Authors:  L C McPhail; P S Shirley; C C Clayton; R Snyderman
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

5.  Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system.

Authors:  J T Curnutte
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

6.  Association of a Ras-related protein with cytochrome b of human neutrophils.

Authors:  M T Quinn; C A Parkos; L Walker; S H Orkin; M C Dinauer; A J Jesaitis
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

7.  Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease.

Authors:  K J Lomax; T L Leto; H Nunoi; J I Gallin; H L Malech
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

8.  Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase.

Authors:  B D Volpp; W M Nauseef; J E Donelson; D R Moser; R A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

Authors:  R A Clark; H L Malech; J I Gallin; H Nunoi; B D Volpp; D W Pearson; W M Nauseef; J T Curnutte
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

10.  Certain lymphoid cells contain the membrane-associated component of the phagocyte-specific NADPH oxidase.

Authors:  E Pick; R Gadba
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

View more
  10 in total

Review 1.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.

Authors:  Pham My-Chan Dang; Allan Stensballe; Tarek Boussetta; Houssam Raad; Cedric Dewas; Yolande Kroviarski; Gilles Hayem; Ole N Jensen; Marie-Anne Gougerot-Pocidalo; Jamel El-Benna
Journal:  J Clin Invest       Date:  2006-06-15       Impact factor: 14.808

3.  Midazolam induces cellular apoptosis in human cancer cells and inhibits tumor growth in xenograft mice.

Authors:  Siddhartha Kumar Mishra; Ju-Hee Kang; Chang Woo Lee; Seung Hyun Oh; Jun Sun Ryu; Yun Soo Bae; Hwan Mook Kim
Journal:  Mol Cells       Date:  2013-09-02       Impact factor: 5.034

4.  Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox.

Authors:  L Zhen; A A King; Y Xiao; S J Chanock; S H Orkin; M C Dinauer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

Authors:  S Sekhsaria; J I Gallin; G F Linton; R M Mallory; R C Mulligan; H L Malech
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis.

Authors:  L R Faust; J el Benna; B M Babior; S J Chanock
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes.

Authors:  Sahra Amel Belambri; Margarita Hurtado-Nedelec; Abderrahmane Senator; Karama Makni-Maalej; Michèle Fay; Marie-Anne Gougerot-Pocidalo; Jean-Claude Marie; Pham My-Chan Dang; Jamel El-Benna
Journal:  Am J Blood Res       Date:  2012-10-20

Review 8.  Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Authors:  Michael J Surace; Michelle L Block
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

Review 9.  NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.

Authors:  Cinzia Sindona; Giovanni Schepici; Valentina Contestabile; Placido Bramanti; Emanuela Mazzon
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

10.  Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA.

Authors:  F E Maly; C C Schuerer-Maly; L Quilliam; C G Cochrane; P E Newburger; J T Curnutte; M Gifford; M C Dinauer
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.